These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 12631617)
1. Expression of p27(Kip1) and c-Jun activation binding protein 1 are inversely correlated in systemic anaplastic large cell lymphoma. Rassidakis GZ; Claret FX; Lai R; Zhang Q; Sarris AH; McDonnell TJ; Medeiros LJ Clin Cancer Res; 2003 Mar; 9(3):1121-8. PubMed ID: 12631617 [TBL] [Abstract][Full Text] [Related]
2. Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1). Kouvaraki MA; Rassidakis GZ; Tian L; Kumar R; Kittas C; Claret FX Cancer Res; 2003 Jun; 63(11):2977-81. PubMed ID: 12782606 [TBL] [Abstract][Full Text] [Related]
3. Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors. Sui L; Dong Y; Ohno M; Watanabe Y; Sugimoto K; Tai Y; Tokuda M Clin Cancer Res; 2001 Dec; 7(12):4130-5. PubMed ID: 11751512 [TBL] [Abstract][Full Text] [Related]
4. Jun activation domain binding protein 1 expression is associated with low p27(Kip1)levels in node-negative breast cancer. Esteva FJ; Sahin AA; Rassidakis GZ; Yuan LX; Smith TL; Yang Y; Gilcrease MZ; Cristofanilli M; Nahta R; Pusztai L; Claret FX Clin Cancer Res; 2003 Nov; 9(15):5652-9. PubMed ID: 14654548 [TBL] [Abstract][Full Text] [Related]
5. Jun activation domain-binding protein 1 expression in malignant lymphoma of the thyroid: its linkage to degree of malignancy and p27 expression. Ito Y; Yoshida H; Matsuzuka F; Matsuura N; Nakamura Y; Nakamine H; Kakudo K; Kuma K; Miyauchi A Anticancer Res; 2003; 23(5b):4121-5. PubMed ID: 14666612 [TBL] [Abstract][Full Text] [Related]
6. Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1. Jeon JH; Lee KN; Hwang CY; Kwon KS; You KH; Choi I Cancer Res; 2005 Jun; 65(11):4485-9. PubMed ID: 15930262 [TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of Jab1 expression in laryngeal squamous cell carcinomas. Dong Y; Sui L; Watanabe Y; Yamaguchi F; Hatano N; Tokuda M Clin Cancer Res; 2005 Jan; 11(1):259-66. PubMed ID: 15671554 [TBL] [Abstract][Full Text] [Related]
8. Thioredoxin modulates activator protein 1 (AP-1) activity and p27Kip1 degradation through direct interaction with Jab1. Hwang CY; Ryu YS; Chung MS; Kim KD; Park SS; Chae SK; Chae HZ; Kwon KS Oncogene; 2004 Nov; 23(55):8868-75. PubMed ID: 15480426 [TBL] [Abstract][Full Text] [Related]
9. Differential expression and clinical significance of tyrosine-phosphorylated STAT3 in ALK+ and ALK- anaplastic large cell lymphoma. Khoury JD; Medeiros LJ; Rassidakis GZ; Yared MA; Tsioli P; Leventaki V; Schmitt-Graeff A; Herling M; Amin HM; Lai R Clin Cancer Res; 2003 Sep; 9(10 Pt 1):3692-9. PubMed ID: 14506160 [TBL] [Abstract][Full Text] [Related]
10. Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1. Kleemann R; Hausser A; Geiger G; Mischke R; Burger-Kentischer A; Flieger O; Johannes FJ; Roger T; Calandra T; Kapurniotu A; Grell M; Finkelmeier D; Brunner H; Bernhagen J Nature; 2000 Nov; 408(6809):211-6. PubMed ID: 11089976 [TBL] [Abstract][Full Text] [Related]
11. Leukotriene B4 receptor inhibitor LY293111 induces cell cycle arrest and apoptosis in human anaplastic large-cell lymphoma cells via JNK phosphorylation. Zhang W; McQueen T; Schober W; Rassidakis G; Andreeff M; Konopleva M Leukemia; 2005 Nov; 19(11):1977-84. PubMed ID: 16151469 [TBL] [Abstract][Full Text] [Related]
12. Biochemical differences between SUDHL-1 and KARPAS 299 cells derived from t(2;5)-positive anaplastic large cell lymphoma are responsible for the different sensitivity to the antiproliferative effect of p27(Kip1). Turturro F; Frist AY; Arnold MD; Seth P; Pulford K Oncogene; 2001 Jul; 20(33):4466-75. PubMed ID: 11494142 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis B virus pre-S2 mutant surface antigen induces degradation of cyclin-dependent kinase inhibitor p27Kip1 through c-Jun activation domain-binding protein 1. Hsieh YH; Su IJ; Wang HC; Tsai JH; Huang YJ; Chang WW; Lai MD; Lei HY; Huang W Mol Cancer Res; 2007 Oct; 5(10):1063-72. PubMed ID: 17951406 [TBL] [Abstract][Full Text] [Related]
14. Inverse expression of Jun activation domain binding protein 1 and cell cycle inhibitor p27Kip1: influence on proliferation in hepatocellular carcinoma. Berg JP; Zhou Q; Breuhahn K; Schirmacher P; Patil MA; Chen X; Schäfer N; Höller TT; Fischer HP; Büttner R; Gütgemann I Hum Pathol; 2007 Nov; 38(11):1621-7. PubMed ID: 17651785 [TBL] [Abstract][Full Text] [Related]
15. Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas. Bai M; Vlachonikolis J; Agnantis NJ; Tsanou E; Dimou S; Nicolaides C; Stefanaki S; Pavlidis N; Kanavaros P Mod Pathol; 2001 Nov; 14(11):1105-13. PubMed ID: 11706071 [TBL] [Abstract][Full Text] [Related]
16. Cyclin dependent kinase inhibitor p27(Kip1) is upregulated by hypoxia via an ARNT dependent pathway. Wang G; Reisdorph R; Clark RE; Miskimins R; Lindahl R; Miskimins WK J Cell Biochem; 2003 Oct; 90(3):548-60. PubMed ID: 14523989 [TBL] [Abstract][Full Text] [Related]
17. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas. Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732 [TBL] [Abstract][Full Text] [Related]
19. Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors. Korbonits M; Chahal HS; Kaltsas G; Jordan S; Urmanova Y; Khalimova Z; Harris PE; Farrell WE; Claret FX; Grossman AB J Clin Endocrinol Metab; 2002 Jun; 87(6):2635-43. PubMed ID: 12050228 [TBL] [Abstract][Full Text] [Related]
20. Signal transducer and activator of transcription-3 activation contributes to high tissue inhibitor of metalloproteinase-1 expression in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Lai R; Rassidakis GZ; Medeiros LJ; Ramdas L; Goy AH; Cutler C; Fujio Y; Kunisada K; Amin HM; Gilles F Am J Pathol; 2004 Jun; 164(6):2251-8. PubMed ID: 15161657 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]